Navigating advance-care-planning conversations across differing cultural, religious, and family-structure norms — with humility, not assumption
Cultural humility, articulated by Melanie Tervalon and Jann Murray-García in 1998, reframes cross-cultural clinical skill away from a checklist of facts about groups and toward an ongoing process of self-reflection, power-awareness, and lifelong learning. Before a clinician can responsibly navigate a patient's cultural context around dying, they need to notice that their own default framework — often an autonomy-centered, individual-disclosure model drawn from Western bioethics — is itself a cultural position, not a neutral clinical baseline.
Cultural competence training, as it developed through the 1990s, often taught clinicians discrete facts about ethnic or religious groups — "Group X prefers Y" — with the implicit promise that enough facts would produce mastery. Tervalon and Murray-García argued this model has a structural flaw: it treats culture as a fixed, learnable body of content, when culture is fluid, intersectional, and expressed differently by every individual within any named group.
Cultural humility instead asks clinicians to hold three practices simultaneously:
• Lifelong learning and critical self-reflection — treating every patient encounter as a chance to examine one's own assumptions, not just the patient's. • Recognizing and addressing power imbalances — between clinician and patient, and between the dominant culture of the health system and the patient's cultural frame. • Institutional accountability — building organizational practices (interpreter access, chaplaincy diversity, flexible visitation) that support humility at the system level, not only the individual encounter level.
In end-of-life discussions specifically, the stakes of getting this wrong are high: a clinician who "knows" that a given ethnic group "doesn't want to be told the truth" may withhold prognostic information from a patient who, individually, wanted it — replacing one paternalism (assuming everyone wants direct disclosure) with another (assuming no one from a given background does).
The corrective is not to abandon pattern knowledge about cultural tendencies — that knowledge is genuinely useful as a starting hypothesis — but to hold it loosely, disclose it transparently to the patient and family as a question rather than a conclusion, and let the individual patient's stated preference override any generalization every time.
Much of contemporary US and Northern European clinical ethics is built on principlism (Beauchamp and Childress, Principles of Biomedical Ethics, first published 1979), which places respect for individual patient autonomy as a load-bearing pillar alongside beneficence, nonmaleficence, and justice. This framework has done enormous good — it dismantled a era of unchecked physician paternalism — but it also encodes a specific cultural assumption: that the patient, as an individual, is the appropriate locus of medical decision-making and information control.
That assumption is not universal. In many family-centered and communitarian traditions — documented across East Asian, Mediterranean, Middle Eastern, Latin American, and numerous Indigenous and African cultural contexts, among others — the family or kin group, not the individual alone, is the natural unit of decision-making, and protecting a beloved family member from distressing information can be experienced as an act of care and loyalty rather than a violation of rights. Kagawa-Singer and Blackhall's influential 2001 JAMA article, "Negotiating Cross-Cultural Issues at End of Life: You Got to Go Where He Lives," argued that clinicians must meet each patient's framework on its own terms rather than requiring assimilation into a single normative model of a "good death."
Recognizing this does not mean discarding autonomy as a value — many patients across every cultural background do want direct information and personal control over decisions. It means recognizing that autonomy itself can be exercised in different forms: a patient can autonomously choose to delegate decision-making to family, and that delegation is itself an expression of self-determination, not a failure of it.
Before entering a serious-illness or end-of-life conversation, clinicians practicing cultural humility pause to ask themselves several questions, not about the patient, but about their own frame:
• What do I assume a "good death" looks like, and where did that assumption come from? • Am I treating direct disclosure of prognosis as inherently more honest or respectful than family-mediated disclosure — and is that a clinical judgment or a cultural preference of my own training? • Do I know this patient's individual preferences, or am I inferring them from a demographic category (surname, accent, appearance, insurance form)? • What power do I hold in this interaction — as the credentialed expert, as a member of the dominant-language group, as a representative of an institution the patient may have reason to distrust — and how might that shape what the patient or family feel able to say to me?
This self-assessment is not a one-time credential. It is repeated, in some form, before every high-stakes cross-cultural conversation, because humility is a practice, not a certificate.
A foundational and frequently skipped step in advance care planning is establishing, explicitly, who the patient wants making decisions and who they want informed. Decision-making authority in serious illness ranges along a spectrum from strict individual autonomy to fully family- or elder-centered deliberation, and a given patient's position on that spectrum is not reliably predictable from ethnicity, religion, or country of origin alone — it must be asked.
Blackhall and colleagues' 1995 JAMA study, "Ethnicity and Attitudes Toward Patient Autonomy," surveyed elderly subjects from four ethnic groups in Los Angeles — Korean American, Mexican American, African American, and European American — about who should be told a terminal diagnosis and who should make decisions about life-sustaining treatment. The study found statistically significant differences between groups: Korean American and Mexican American subjects were, on average, considerably less likely than African American and European American subjects to believe the patient should be told a terminal prognosis directly, and less likely to believe the patient alone (rather than the family) should make decisions about life support.
This kind of finding is genuinely useful — it demonstrates that decision-making norms are not incidental cultural trivia but measurable, clinically relevant variation that shapes what a respectful conversation looks like. But the same body of research, and the decades of work that followed it, consistently emphasizes a second finding that is just as important: variation within any named ethnic or religious group is typically as large as, or larger than, variation between groups. Acculturation, generation since immigration, socioeconomic status, education, individual family history, prior experience with illness and healthcare systems, and simple individual temperament all shape where a given patient falls on the spectrum — often more than group membership does.
The clinical implication is that these studies should be read as evidence that the spectrum exists and matters, not as a lookup table for predicting any individual patient's preference.
It is important to describe family-centered decision-making accurately: it is not a lesser or less-evolved version of individual autonomy, and it is not synonymous with excluding the patient. In many communitarian traditions, the self is understood relationally — as embedded within, and partly constituted by, a network of family obligations — so a decision made collectively by the family, ideally still reflecting the patient's own values and wishes as understood by people who know them intimately, is experienced as legitimate and often more trustworthy than a decision made by the patient in clinical isolation.
Family-centered models take several forms in practice:
• Filial/elder-deferential models — adult children take a leading role in decisions for an aging parent, often framed as a reciprocal duty of care (this pattern is widely described in Confucian-influenced East Asian contexts, but appears across many other traditions as well). • Spousal/patriarchal or matriarchal head-of-household models — a spouse or designated family elder is the primary interlocutor and decision-maker, common in a range of Middle Eastern, South Asian, and Latin American family structures, again with wide individual variation. • Consensus/council models — decisions emerge from extended-family or community deliberation rather than a single authority figure, described in some Indigenous, Pacific Islander, and African communal traditions.
None of these models is a monolith even within the tradition that is said to typify it, and none should be assumed present just because a patient's name, language, or appearance suggests a particular background.
A structured way to open this assessment, adapted from cross-cultural communication frameworks used in serious-illness training (including elements of the LEARN model — Listen, Explain, Acknowledge, Recommend, Negotiate — developed by Berlin and Fowkes in 1983), is to ask directly and early, ideally before any difficult news needs to be delivered:
"As we talk about your health going forward, I want to make sure I involve the right people in the right way. Who would you like to be part of these conversations? Is there someone you'd like to lead on decisions, or would you prefer to decide for yourself? And is there anyone you'd like me to keep informed, even if they're not making the decisions?"
This question accomplishes several things at once: it signals respect rather than assumption, it surfaces the patient's actual preference (which may itself be "please talk to my son," a fully autonomous and valid answer), and it creates a documented, revisitable record — because preferences can shift as illness progresses, as trust builds with the care team, or as family dynamics change. Revisiting the question periodically, rather than treating one early answer as permanent, is considered good practice precisely because both illness and relationships evolve.
Direct, unfiltered disclosure of a terminal prognosis to the patient is standard practice in much of contemporary US and Northern European medicine, grounded in the principle of informed consent. But this is a relatively recent norm even in Western medicine — as late as the 1960s, US physicians frequently withheld cancer diagnoses from patients — and it remains far from universal globally. In many cultural contexts, families and patients prefer that difficult prognostic information be filtered through a family spokesperson, a practice sometimes termed "protective truth-telling."
It is easy to mistake the current US/Northern European norm of full, direct prognostic disclosure as a timeless medical standard, but it is itself a historically recent and culturally specific development. Studies from the mid-20th century found that a large majority of US physicians routinely withheld cancer diagnoses from patients as standard practice; this shifted decisively over the following decades alongside the rise of the informed-consent doctrine and the patient-autonomy movement in bioethics.
Oncologist and bioethicist Antonella Surbone and others have documented that in Italy and much of the broader Mediterranean region, a preference persists — again, as a tendency rather than a rule — for filtering serious diagnostic and prognostic information through the family before, or sometimes instead of, direct disclosure to the patient, particularly for elderly patients. Similar patterns, with their own local variations, have been described in parts of East Asia, the Middle East, and Latin America. The underlying logic in many of these contexts is not that the truth is unimportant, but that hope, morale, and the will to live are understood as having real clinical weight, and that the family — not the physician — is seen as the appropriate protector of the patient's emotional state.
Crucially, this is not simply "culture Y hides the truth." Patients within every one of these cultural contexts include people who want full direct disclosure, and patients within individual-disclosure-dominant cultures who would prefer information go through family. The pattern is a population-level tendency, useful for prompting the right question, not a rule to apply to the person in front of you.
The practical solution that the palliative care and cross-cultural communication literature converges on is not to pick a default (always disclose fully / always ask family first) but to ask the patient directly, early, and before any bad news needs to be delivered, using an explicit, low-pressure question such as:
"Different people want different amounts of information about their health, and that's completely fine either way. Would you like me to share test results and what they might mean directly with you? Or would you prefer I discuss that first with a family member, and let them decide how and when to share it with you? And who, besides yourself, would you like kept informed?"
This question, sometimes formalized in serious-illness communication training under frameworks like ETHNIC (Explanation, Treatment, Healers, Negotiate, Intervention, Collaboration) or the broader "ask-tell-ask" communication skill, has several important properties: it never assumes the answer; it respects that the preference itself is the patient's autonomous choice (delegating disclosure IS an exercise of autonomy, not a suspension of it); it is asked once but documented and revisited, since preferences can change over the course of illness; and it applies to every patient, regardless of apparent cultural background, since assumption in either direction — assuming a patient from a "direct disclosure" background wants everything immediately, or assuming a patient from a "family-filtered" background does not want to know — is equally a failure of individualized care.
When a patient designates a family member to receive and manage information, clinicians document this clearly (sometimes formalized as a "waiver of information" or documented communication preference) so the whole care team honors it consistently, rather than each new clinician re-defaulting to direct disclosure out of habit.
Respecting a family's preference for filtered disclosure does not mean abandoning the patient's right to ask questions directly, and it does not mean permanently withholding information the patient is actively requesting. Tension arises in a few recurring situations: when a family asks the clinician to actively lie if the patient asks a direct question (most palliative care ethics guidance distinguishes between not volunteering unsolicited bad news and affirmatively lying in response to a direct question — the latter is broadly discouraged even within a protective-disclosure framework); when informed consent for a specific procedure legally requires patient-level understanding of risks and prognosis; and when the patient's own behavior (repeatedly asking pointed questions, seeking information from other sources) suggests their stated preference for non-disclosure may not reflect their true current wishes.
A workable middle path used widely in practice is "titrated disclosure": offering information in small increments with an open door — "I have some information about your results. Would you like to hear more now, or should we talk about it with your family present?" — which lets the patient control the pace and amount without forcing an all-or-nothing choice at any single moment.
Major religious and spiritual traditions offer substantive, often sophisticated frameworks for thinking about withdrawing life-sustaining treatment, artificial nutrition and hydration, hospice enrollment, and organ donation. These frameworks are not monolithic — every tradition contains real internal diversity across denominations, schools of legal/ethical interpretation, and individual belief — so the summaries below describe documented mainstream positions as starting points for conversation, never as a substitute for asking the patient, family, and, ideally, their own chaplain or religious leader.
Catholic moral theology draws a widely cited distinction, traceable to a 1957 address by Pope Pius XII and elaborated since in official guidance such as the US Conference of Catholic Bishops' Ethical and Religious Directives for Catholic Health Care Services, between "ordinary" (proportionate, reasonably beneficial, not excessively burdensome) means of preserving life, which are considered obligatory, and "extraordinary" or disproportionate means, which may be withheld or withdrawn without this constituting euthanasia — a practice the Church distinguishes clearly and prohibits. What counts as "extraordinary" is assessed relative to the patient's condition and prognosis, not fixed to a specific technology, so a ventilator that is burdensome and non-beneficial for a dying patient can licitly be withdrawn even though the same treatment might be obligatory in a recoverable patient.
Artificial nutrition and hydration (ANH) has been a genuinely debated question within Catholic moral theology: a 2004 papal allocution by John Paul II argued for a strong presumption in favor of continuing ANH even in persistent vegetative state, treating it as basic care rather than medical treatment; this generated substantial theological discussion, and the US bishops' directives were subsequently revised (2009) to reflect a presumption in favor of providing ANH while still permitting withdrawal when it would not prolong life, would be excessively burdensome, or could not be assimilated by the patient's body. In practice, individual Catholic patients, families, and even theologians hold a range of views on ANH specifically, making direct conversation essential.
Protestant Christianity spans enormous denominational diversity — from traditions broadly comfortable with withdrawing treatment and embracing hospice as consonant with accepting mortality and trusting an afterlife, to more conservative traditions emphasizing that only God should determine the moment of death and expressing caution about anything that could be framed as hastening it. Jehovah's Witnesses are a distinct and well-documented case: adherents typically decline blood transfusions on scriptural grounds and often carry advance directive cards specifying this, while otherwise generally accepting other palliative and end-of-life care consistent with individual wishes.
In Jewish tradition, pikuach nefesh — the preservation of life — is regarded in Orthodox halakha as an extremely high value, sometimes described as overriding most other religious obligations. This generates a strong, though not absolute, presumption toward continuing life-sustaining treatment. At the same time, many halakhic authorities distinguish between actively hastening death, which is prohibited, and removing an impediment that is artificially prolonging the dying process of a patient already classified as a goses (actively, imminently dying) — a distinction that in practice can permit withdrawing certain interventions (for example, not restarting a treatment, or discontinuing something classified as an "impediment" rather than ordinary sustenance) even while maintaining a strong presumption against withdrawal in general. Positions vary meaningfully across Orthodox, Conservative, and Reform authorities, with more liberal movements generally more permissive of withdrawing treatment and enrolling in hospice. Organ donation is genuinely contested within Jewish law, in part because of disagreement among poskim (halakhic decisors) about whether brain-stem death satisfies the traditional definition of death (historically tied to cessation of cardiopulmonary function) — meaning a family's answer on organ donation cannot be predicted from "being Jewish" alone and requires direct conversation, often with the patient's own rabbi.
In Islamic tradition, the overwhelming majority of contemporary scholarly opinion holds that withholding or withdrawing treatment that is medically futile, when death is recognized as inevitable, is permissible and distinct from euthanasia (qatl al-rahma / "mercy killing"), which is prohibited as a form of ending life. Advance directives and hospice-style comfort-focused care are generally compatible with this framework once curative treatment is understood to be futile. Brain death is accepted as equivalent to death by many, though not all, schools of Islamic jurisprudence and national fatwa councils, so practices and family expectations around ventilator withdrawal after a brain-death determination can vary. Family involvement, and consultation with a trusted imam or religious scholar, is frequently an important and expected part of decision-making, and organ donation has been permitted by numerous contemporary fatwas under specified conditions (saving a life, no commercial trade, consent), while remaining a point of debate among some scholars and communities.
Buddhist traditions vary considerably across schools (Theravada, Mahayana, Vajrayana) and cultures, but commonly emphasize the importance of a clear, conscious mind at the moment of death, since the state of consciousness at death is often held to influence what follows; this leads some Buddhist patients or families to prefer minimizing sedating medications near the very end of life even at some cost to comfort, though this is far from universal and many Buddhist patients prioritize comfort-focused sedation like any other patient. Karma and rebirth beliefs can shape how patients and families understand suffering and make meaning of the dying process, and a calm, supported death is often valued highly, making hospice philosophy broadly compatible with Buddhist practice when individualized appropriately.
Hindu traditions likewise show wide regional and denominational diversity. Some patients and families place value on dying at home, in a state of awareness, sometimes with specific ritual elements (such as being placed on the ground, chanting, or the presence of Ganges water) considered significant; family presence at the deathbed is frequently emphasized. Views on artificial life support vary widely by individual belief and region, and organ donation, while historically contested in some interpretations, has grown more accepted alongside modern medical and religious dialogue in many Hindu communities.
Many Indigenous traditions across North America, the Pacific, and elsewhere emphasize communal or consensus decision-making, specific culturally meaningful practices around the dying process and the handling of the body, and a preference for dying in the presence of community and on one's own land or in a culturally significant place — again, with enormous variation across the hundreds of distinct nations and communities these traditions represent, resisting any single summary.
Across all of these traditions, the single most consistently recommended practice in the palliative care literature is the same: involve chaplaincy or the patient's own religious leader as a core, proactive member of the care team — not a referral made only after a crisis — and ask the patient and family directly what matters to them, using the tradition's documented tendencies only as a starting point for that conversation, never as its conclusion.
Two safeguards anchor culturally competent end-of-life communication in practice. First, high-stakes prognostic and goals-of-care conversations should always use a qualified, professional medical interpreter — never an ad hoc family member, and never a minor child — because the evidence on interpretation quality and its clinical consequences is unambiguous. Second, every piece of cultural-pattern knowledge in this simulation is a hypothesis to test with the individual patient in front of you, never a rule to apply to them.
A substantial body of research, including a frequently cited 2003 Pediatrics study by Flores and colleagues on errors in medical interpretation, found that interpretation performed by untrained ad hoc interpreters — family members, friends, bilingual staff pulled from other duties, or children — produced errors of potential clinical consequence at a much higher rate than interpretation performed by trained professional interpreters. Errors documented in this literature include omissions of clinically important information, substitutions that change meaning, editorializing (the interpreter inserting their own opinion or softening bad news), and false fluency (an interpreter who is conversationally bilingual but lacks the specialized medical vocabulary to convey precise clinical concepts).
For end-of-life conversations specifically, using a family member as interpreter carries additional, distinct problems beyond translation accuracy: the family member is simultaneously an emotionally invested party in the outcome, may consciously or unconsciously filter or soften prognostic information they find distressing (collapsing the very distinction this simulation asks clinicians to preserve — the patient/family's right to choose a disclosure preference, versus an interpreter unilaterally deciding what to convey), may be placed in the ethically inappropriate position of being asked to deliver news they themselves are grieving, and — when the family member is a minor child — raises serious concerns about developmental appropriateness and long-term psychological burden that most institutional policies and much clinical ethics guidance treat as categorically inappropriate for anything beyond simple, low-stakes exchanges.
In the United States, Title VI of the Civil Rights Act of 1964 and subsequent guidance require that healthcare organizations receiving federal funding provide meaningful language access, and the Joint Commission's standards specifically call for qualified language services in the provision of care — a legal and accreditation backdrop, not merely a best-practice suggestion.
Effective use of a professional medical interpreter is itself a skill. Practices generally recommended in serious-illness communication training include:
• Brief the interpreter before the conversation — explain the purpose of the meeting, the key information to be conveyed, and any particularly sensitive content (a terminal diagnosis, a discussion of withdrawing treatment) so the interpreter is not encountering it cold in front of the family. • Speak directly to the patient and family, in the first person ("I recommend..." rather than "tell them I recommend..."), maintaining eye contact with the patient rather than the interpreter, who functions as a transparent conduit for the conversation, not its addressee. • Use short, clear segments rather than long monologues, giving the interpreter manageable chunks to render accurately and completely. • Debrief afterward — professional interpreters can offer valuable observations about communication dynamics, family reactions, or cultural context they noticed, functioning at times as a "cultural broker" in addition to a linguistic one, when the clinician explicitly invites that input rather than assuming it. • Use qualified interpretation for every language-discordant high-stakes conversation, including video remote interpreting (VRI) or telephonic interpreting when in-person interpreters for a specific language are not available — modern interpreter services make 24/7 access to rare-language interpretation realistic in most well-resourced health systems.
Even fluent bilingual clinicians should generally use a professional interpreter for the most consequential conversations (terminal diagnosis disclosure, code status, withdrawal of life support) unless they hold specific medical interpreter certification themselves, since conversational fluency and the specialized precision required for informed consent in a second language are different skills.
Every pattern described across this simulation — a tendency toward family-centered decision-making, a preference for protective disclosure, a religious tradition's typical stance on withdrawing treatment — is drawn from real, documented research and represents genuine, clinically useful population-level knowledge. But population-level tendencies describe distributions, not individuals, and the research summarized here consistently finds that within-group variation is often as large as, or larger than, between-group variation.
Stereotyping in cross-cultural end-of-life care most often does not look like open bigotry. It looks like a well-intentioned clinician who, having learned that "patients from background X often prefer family-mediated disclosure," stops asking the individual patient in front of them what they want — silently applying a group-level pattern as an individual-level rule, in either direction (assuming a patient wants less information than they do, or assuming a patient from a "direct disclosure" background wants more than they do).
The practices this simulation walks through — cultural humility as an ongoing stance rather than a credential, explicitly asking about decision-making structure and disclosure preference rather than assuming them, engaging chaplaincy and religious leadership as genuine collaborators rather than checkbox referrals, and using professional interpretation for high-stakes conversations — share a common structure: each replaces an assumption with a question, asked directly to the patient and family, and revisited over time as illness, relationships, and preferences evolve. Cultural knowledge earns its clinical value only when it is used to generate better questions, not to skip asking them.